Integra Therapeutics
PrivateLast Round
VC Round
Sep 8, 2025
Total Funding Raised
$27.6M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Integra Therapeutics is a biotechnology company that creates next-generation gene writing tools to improve the safety and efficacy of advanced therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Integra Therapeutics Comparables
Compare Integra Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tessera Therapeutics | 81% | |
| T-CURX GmbH | 78% | |
| Demeetra AgBio | 77% |
Integra Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Sep 8, 2025 | ||||
| Grant | Jul 17, 2024 | ||||
| Early Funding | Sep 8, 2023 | ||||
| Seed | Mar 30, 2022 | ||||
| Seed | Dec 2, 2021 |
Key People
Founding team and executive leadership
Integra Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| CDTI Innvierte | Early Funding, VC Round |
| Pompeu Fabra University | VC Round, Seed |
| Center for Technological Development and Innovation | VC Round |
| Takeda Ventures | VC Round, Early Funding, Seed |
| Invivo Partners | VC Round, Early Funding, Seed |
| Columbus Venture Partners | Seed, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 20, 2026
Monthly visitors grew 32% MoM, reaching 3.5K.
- May 16, 2026
Monthly visitors increased 93% MoM.
Integra Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Integra Therapeutics's valuation, stock price, and market status.
Is IntegraTherapeutics a public or private company?
IntegraTherapeutics is a private company.
What is the current stock price of IntegraTherapeutics?
IntegraTherapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is IntegraTherapeutics worth (valuation)?
Valuation information for IntegraTherapeutics is not publicly available.
Can I buy IntegraTherapeutics stock?
IntegraTherapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was IntegraTherapeutics's last funding round?
IntegraTherapeutics's most recent funding round was VC Round on September 8, 2025.
Who are the main investors in IntegraTherapeutics?
Key investors in IntegraTherapeutics include Center for Technological Development and Innovation, EIC Fund.
Will IntegraTherapeutics IPO soon?
No public IPO plans have been announced for IntegraTherapeutics.
How can I track IntegraTherapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor IntegraTherapeutics's secondary market activity and sign up for updates.